GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+71.81%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$1.04B
AUM Growth
+$1.04B
(+10%)
Cap. Flow
-$156M
Cap. Flow
% of AUM
-14.99%
Top 10 Holdings %
Top 10 Hldgs %
69.3%
Holding
51
New
15
Increased
5
Reduced
11
Closed
15
Top Buys
| 1 |
NextCure
NXTC
|
$63.9M |
| 2 |
TG Therapeutics
TGTX
|
$60.3M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$57.5M |
| 4 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
$53.5M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$35.3M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$82.4M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$69.8M |
| 3 |
Penumbra
PEN
|
$40.3M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$40.2M |
| 5 |
Nektar Therapeutics
NKTR
|
$38.7M |
Sector Composition
| 1 | Healthcare | 95.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Iovance Biotherapeutics
IOVA
$807M
| $139M | 12.09% | 5,015,175 -245,628 | -5% | -$6.8M |
|
2
Zymeworks
ZYME
$1.12B
| $101M | 8.8% | 2,223,789 -242,955 | -10% | -$11M |
|
3
PTC Therapeutics
PTCT
$3.92B
| $84.1M | 7.32% | 1,750,000 -250,000 | -13% | -$12M |
|
|
4
NextCure
NXTC
$13.5M
| $63.9M | 5.56% | +1,134,584 | New | +$63.9M |
|
|
5
TG Therapeutics
TGTX
$4.65B
| $60.3M | 5.25% | +5,434,783 | New | +$60.3M |
|
|
SAGE
6
DELISTED
Sage Therapeutics
SAGE
| $57.5M | 5% | +796,057 | New | +$57.5M |
|
|
MNTA
7
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $55.1M | 4.79% | 2,790,400 +1,790,400 | +179% | +$35.3M |
|
|
CNST
8
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $53.5M | 4.66% | +1,135,122 | New | +$53.5M |
|
|
9
Acadia Pharmaceuticals
ACAD
$4.38B
| $53.5M | 4.66% | 1,250,000 -940,742 | -43% | -$40.2M |
|
|
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
| $53M | 4.62% | 1,000,000 -454,700 | -31% | -$24.1M |
|
11
United Therapeutics
UTHR
$13.8B
| $47.7M | 4.15% | 541,179 +71,179 | +15% | +$6.27M |
|
|
DERM
12
DELISTED
Dermira, Inc.
DERM
| $39.7M | 3.46% | 2,621,333 | – | – |
|
13
Prothena Corp
PRTA
$441M
| $33.3M | 2.9% | 2,100,941 +34,900 | +2% | +$552K |
|
14
Abeona Therapeutics
ABEO
$350M
| $23.6M | 2.05% | 7,213,012 +3,977,411 | +123% | +$13M |
|
15
Arvinas
ARVN
$568M
| $22.6M | 1.97% | +550,000 | New | +$22.6M |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| $21.9M | 1.91% | 420,000 -1,580,000 | -79% | -$82.4M |
|
17
Tandem Diabetes Care
TNDM
$845M
| $14.9M | 1.3% | 250,000 | – | – |
|
|
GWPH
18
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $14.8M | 1.29% | +141,683 | New | +$14.8M |
|
|
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12.9M | 1.13% | +466,507 | New | +$12.9M |
|
20
Kura Oncology
KURA
$686M
| $11.7M | 1.02% | 853,777 -2,232,276 | -72% | -$30.7M |
|
21
Tempest Therapeutics
TPST
$44M
| $11.7M | 1.02% | 1,729,759 +441,666 | +34% | +$2.98M |
|
|
MTEM
22
DELISTED
Molecular Templates, Inc.
MTEM
| $11.5M | 1% | +825,000 | New | +$11.5M |
|
|
OPTN
23
DELISTED
OptiNose
OPTN
| $10.9M | 0.95% | +1,181,834 | New | +$10.9M |
|
24
VYNE Therapeutics
VYNE
$8.16M
| $7.67M | 0.67% | 1,652,013 | – | – |
|
|
VRAY
25
DELISTED
ViewRay, Inc.
VRAY
| $7.24M | 0.63% | +1,715,153 | New | +$7.24M |
|